blood-brain barrier permeation nanoparticle ligand glutathione

blood-brain barrier permeation nanoparticle ligand glutathione Allosteric targeted drug delivery for enhanced penetration via mimicking transmembrane domain interactions Nanotechnology to Overcome Blood–Brain Barrier

Name: blood-brain barrier permeation nanoparticle ligand glutathione Allosteric targeted drug delivery for enhanced penetration via mimicking transmembrane domain interactions Nanotechnology to Overcome Blood–Brain Barrier
Brand: jacksfamilyfund.org
SKU: 95523058884
Price: 21.83 USD
Availability: InStock
Rating: 4.1215 (22 reviews)

Nanotechnology to Overcome BloodBrain Barrier Permeability and Damage in Neurodegenerative Diseases PMC The bloodbrain barriers: novel nanocarriers for central nervous system diseases Journal of Nanobiotechnology Springer Nature Link Innovative nanoparticle based therapeutic strategies against glioblastoma multiform: a focus on enhanced delivery systems and efficacy PMC Crossing the Blood Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro Oncology Modern methods for delivery of drugs across the bloodbrain barrier ScienceDirect Engineered nanoplatforms for brain targeted co delivery of phytochemicals in Alzheimer's disease: Rational design, blood brain barrier penetration, and multi target therapeutic synergy ScienceDirect

SKU: 95523058884 · From jacksfamilyfund.org

4.1

USD21.83 USD55.83

Pay in 4 interest-free payments of $5.46 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 29 - Aug 3

Description

doi: 10.3390/md23120485, 77

Warnings For external use only Flammable, keep away from flame or fire Not for use with electrocautinary devices or procedures Do not use in eyes Sterile unless package is damaged or open Stop use and ask a doctor if: Irritation or redness develops Condition persists for more than 72 hours Cleansing of an injection site Keep out of reach of children

Cell Mol Neurobiol 43(7):33293341 Wang H et al (2018) Nephropreventing effect of hypoxia-inducible factor 1 in a rat model of ischaemic/reperfusion acute kidney injury